Oncology Meeting Resources
- 04 Mar 2015,
The plenary session themes were quite diverse, providing up-to-date overviews and discussion of the most promising targets and targeted agents under development in early phase clinical studies or ready to begin clinical evaluation after successful preclinical development. Novel immunological targets/agents were also represented in this year’s programme with two plenary sessions entirely devoted to this emerging and already quite successful class of agents and treatments.
On this page, you may view the slide sets of presentations given at the 13th International Congress on Targeted Anticancer Therapies to the extent the presenters have consented to release their contribution or a slightly modified version thereof. Please note that the publication of these presentations is a courtesy of the originating authors and is for personal educational purposes only.